Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Virtual Booth

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 USDMF

1 API Suppliers
1 USDMF

DEVELOPMENTS

7 Drugs in Development

7 Drugs in Development

DIGITAL CONTENT

9 NEWS #PharmaBuzz

media
9 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

7DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 168079-32-1, Vpa-985, Way-vpa-985, Lixar, Vpa 985, N-[3-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-5-fluoro-2-methylbenzamide

Molecular Formula

C₂₇H₂₁ClFN₃O₂

Molecular Weight

473.9 g/mol

InChI Key

PPHTXRNHTVLQED-UHFFFAOYSA-N

FDA UNII

8F5X4B082E

1 2D Structure

Lixivaptan

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

N-[3-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-5-fluoro-2-methylbenzamide

2.1.2 InChI

InChI=1S/C27H21ClFN3O2/c1-17-8-9-19(29)13-23(17)26(33)30-20-10-11-22(24(28)14-20)27(34)32-16-21-6-4-12-31(21)15-18-5-2-3-7-25(18)32/h2-14H,15-16H2,1H3,(H,30,33)

2.1.3 InChI Key

PPHTXRNHTVLQED-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC1=C(C=C(C=C1)F)C(=O)NC2=CC(=C(C=C2)C(=O)N3CC4=CC=CN4CC5=CC=CC=C53)Cl

2.2 Other Identifiers

2.2.1 UNII

8F5X4B082E

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 5-fluoro-2-methyl-n-(4-(5h-pyrrolo(2,1-c)-(1,4)benzodiazepin-10-(11h)-ylcarbonyl)-3-chlorophenyl)benzamide

2. Crtx 080

3. Crtx-080

4. Crtx080

5. N-4-(3-chloro-4-(5h-pyrrolo(2,1-c)(1,4)benzodiazepin-10(11h)-ylcarbonyl)phenyl)-5-fluoro-2-methylbenzamide

6. Vpa 985

7. Vpa-985

8. Way Vpa-985

9. Way-vpa-985

2.3.2 Depositor-Supplied Synonyms

1. 168079-32-1

2. Vpa-985

3. Way-vpa-985

4. Lixar

5. Vpa 985

6. N-[3-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-5-fluoro-2-methylbenzamide

7. Crtx-080

8. Vpa985

9. Chembl49429

10. Crtx 080

11. 8f5x4b082e

12. Lixivaptan [usan:inn]

13. 3'-chloro-5-fluoro-4'-(5h-pyrrolo(2,1-c)(1,4)benzodiazepin-10(11h)-ylcarbonyl)-o-toluanilide

14. Benzamide, N-(3-chloro-4-(5h-pyrrolo(2,1-c)(1,4)benzodiazepin-10(11h)-ylcarbonyl)phenyl)-5-fluoro-2-methyl-

15. Benzamide, N-[3-chloro-4-(5h-pyrrolo[2,1-c][1,4]benzodiazepin-10(11h)-ylcarbonyl)phenyl]-5-fluoro-2-methyl-

16. N-(3-chloro-4-(10,11-dihydro-5h-benzo[e]pyrrolo[1,2-a][1,4]diazepine-10-carbonyl)phenyl)-5-fluoro-2-methylbenzamide

17. Lixivaptan (usan/inn)

18. Way Vpa-985

19. Way-vpa 985

20. Unii-8f5x4b082e

21. Lixivaptan [usan]

22. Lixivaptan [mi]

23. Lixivaptan [inn]

24. Lixivaptan (vpa-985)

25. Lixivaptan [vandf]

26. Lixivaptan [mart.]

27. Lixivaptan [who-dd]

28. Gtpl2238

29. Schembl1649340

30. Dtxsid00168472

31. Hms3747a19

32. Zinc600399

33. Bcp09167

34. Ex-a1129

35. Vpa-985;way-vpa 985

36. Bdbm50065115

37. Mfcd00937905

38. Akos022181388

39. Cs-7512

40. Db06666

41. Ncgc00485402-01

42. Ac-26832

43. Bs-15602

44. Hy-14185

45. Db-064673

46. Ft-0670828

47. D04752

48. L001508

49. 2-chloro-6,7,8,9-tetrahydrobenzocyclohepten-5-one

50. Q6659958

51. 3-chloro-4-(10,11-dihydro-5h-benzo[e]pyrrolo[1,2-a][1,4]diazepin-10-ylcarbonyl)-1-(5-fluoro-2-methylphenylcarboxamido)benzene

52. 5-fluoro-2-methyl-n-(4-(5h-pyrrolo(2,1-c)-(1,4)benzodiazepin-10-(11h)-ylcarbonyl)-3-chlorophenyl)benzamide

53. Benzamide, N-(3-chloro-4-(5h-pyrrolo(2,1-c)(1,4)benzodiazepin-10(11h)-ylcarbonyl)phenyl)-5-fluoro-2-methyl-;

54. N-[4-(5h,11h-benzo[e]pyrrolo[1,2-a][1,4]diazepine-10-carbonyl)-3-chloro-phenyl]-5-fluoro-2-methyl-benzamide

55. N-[4-(5h-pyrrolo[2,1-c][1,4]benzodiazepin-10(11h)-ylcarbony)-3-chlorophenyl]-5-fluoro-2-methylbenzamide

56. N-[4-(5h-pyrrolo[2,1-c][1,4]benzodiazepin-10(11h)-ylcarbonyl)-3-chlorophenyl]-5-fluoro-2-methyl-benzamide

57. N-[4-(5h-pyrrolo[2,1-c][1,4]benzodiazepin-10(11h)-ylcarbonyl)-3-chlorophenyl]-5-fluoro-2-methylbenzamide

58. N-[4-(5h-pyrrolo[2,1-c][1,4]benzodiazepin-10(11h)ylcarbonyl)-3-chlorophenyl]-5-fluoro-2-methylbenzamide

59. N-[4-(5h-pyrrolo[2,1-c][1,4]benzodiazepin10(11h)-ylcarbonyl)-3-chlorophenyl]-5-fluoro-2-methylbenzamide

60. N-4-(3-chloro-4-(5h-pyrrolo(2,1-c)(1,4)benzodiazepin-10(11h)-ylcarbonyl)phenyl)-5-fluoro-2-methylbenzamide

2.4 Create Date

2005-08-09

3 Chemical and Physical Properties

Molecular Formula	C₂₇H₂₁ClFN₃O₂
Molecular Weight	473.9 g/mol
XLogP3	4.8
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	3
Rotatable Bond Count	3
Exact Mass	473.1306328 g/mol
Monoisotopic Mass	473.1306328 g/mol
Topological Polar Surface Area	54.3 Å²
Heavy Atom Count	34
Formal Charge	0
Complexity	753
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1